Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Koike, R. Kannagi, Y. Takuma, F. Akutsu, S. Hayashi, N. Hiraiwa, K. Kadomatsu, T. Muramatsu, H. Yamakawa, T. Nagai, Shoji Kobayashi, H. Okada, I. Nakashima, K. Uchida, I. Yokoyama, H. Takagi (1996)
Introduction of α(1,2)‐fucosyltransferase and its effect on a‐Gal epitopes in transgenic pigXenotransplantation, 3
M. Sandrin, W. Fodor, S. Cohney, E. Mouhtouris, N. Osman, S. Rollins, S. Squinto, I. McKenzie (1996)
Reduction of the major porcine xenoantigen Galoc(1,3)Gal by expression of α(1,2)fucosyltransferaseXenotransplantation, 3
I. Grupp, A. Subramaniam, T. Hewett, J. Robbins, G. Grupp (1993)
Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations.The American journal of physiology, 265 4 Pt 2
R. Tearle, M. Tange, Z. Zannettino, Marina Katerelos, T. Shinkel, B. Denderen, A. Lonie, I. Lyons, M. Nottle, T. Cox, C. Becker, A. Peura, P. Wigley, Robert Crawford, Allan Robins, Martin Pearse, A. D'apice (1996)
The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation.Transplantation, 61 1
R. Oriol, Y. Ye, E. Koren, D. Cooper (1993)
CARBOHYDRATE ANTIGENS OF PIG TISSUES REACTING WITH HUMAN NATURAL ANTIBODIES AS POTENTIAL TARGETS FOR HYPERACUTE VASCULAR REJECTION IN PIG‐TO‐MAN ORGAN XENOTRANSPLANTATION1Transplantation, 56
D. Cooper, Goodwin Ah, E. Koren, R. Oriol, Malcolm Aj, Ippolito Rm, F. Neethling, Y. Ye, E. Romano, N. Zuhdi (1993)
Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man.Transplant immunology, 1 3
U. Galili, S. Shohet, E. Kobrin, C. Stults, B. Macher (1988)
Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.The Journal of biological chemistry, 263 33
U. Galili, B. Macher, J. Buehler, S. Shohet (1985)
Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residuesThe Journal of Experimental Medicine, 162
Y. Ye, F. Neethling, M. Niekrasz, Eugen Koren, S. Richards, M. Martin, Stanley Kosanke, Rafael Oriol, D. Cooper (1994)
Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts.Transplantation, 58 3
W. Baldwin, Scott Pruitt, Robert Brauer, M. Daha, Fred Sanfilippo (1995)
Complement in organ transplantation. Contributions to inflammation, injury, and rejection.Transplantation, 59 6
D. Cooper, Y. Ye, L. Rolf, N. Zuhdi (1991)
The Pig as Potential Organ Donor for ManTransplantation, 57
U. Galili, Karen Swanson (1991)
Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys.Proceedings of the National Academy of Sciences of the United States of America, 88
D. Cooper, E. Koren, B. Oriol (1996)
Manipulation of the anti‐αGal antibody‐αGal epitope system in experimental discordant xenotransplantationXenotransplantation, 3
Nikolaos Papadopoulos, George Dedoussis, Gregory Spanakos, A. Gritzapis, C. Baxevanis, M. Papamichail (1994)
An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry.Journal of immunological methods, 177 1-2
B. Morgan, D. Imagawa, J. Dankert, L. Ramm (1986)
Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.Journal of immunology, 136 9
M. Panaccio, M. Georgesz, A. Lew (1993)
FoLT PCR: a simple PCR protocol for amplifying DNA directly from whole blood.BioTechniques, 14 2
U. Galili, R. Mandrell, Randa Hamadeh, S. Shohet, J. Griffiss (1988)
Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human floraInfection and Immunity, 56
P. Cowan, T. Shinkel, E. Witort, H. Barlow, M. Pearse, A. D'apice (1996)
Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule 2 promoter.Transplantation, 62 2
R. Brooimans, A. Ark, Motowo Tomita, L. Es, M. Daha (1992)
CD59 expressed by human endothelial cells functions as a protective molecule against complement‐mediated lysisEuropean Journal of Immunology, 22
Galili Galili (1993)
Evolution and pathophysiology of the human natural anti‐oc‐galactosyl IgG (anti‐Gal) antibodySpringer Semin Immunopathol, 15
Peter Lachmann (1991)
The control of homologous lysis.Immunology today, 12 9
I. Štefanov́a, I. Hilgert, H. Krištofová, Ronald Brown, M. Low, V. Hořejší (1989)
Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol.Molecular immunology, 26 2
Galili Galili, Macher Macher, Buchler Buchler, Shohet Shohet (1985)
Human natural anti‐oc galactosyl IgG. H The specific recognition of α(1,3) linked galactosyl residuesJ Exp Med, 162
Galili Galili, Mandrell Mandrell, Hamedeh Hamedeh, Shohet Shohet, Griffiths Griffiths (1988)
Interaction between natrual anti‐a‐galac‐tosyl immunoglobulin G and bacterial of the human floraImmun Infect, 56
L. Diamond, K. McCurry, Michael Martin, S. McClellan, Elizabeth Oldham, Jeffrey Platt, John Logan (1996)
Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium.Transplantation, 61 8
N. Suttorp, W. Seeger, S. Zinsky, S. Bhakdi (1987)
Complement complex C5b-8 induces PGI2 formation in cultured endothelial cells.The American journal of physiology, 253 1 Pt 1
Chao-Guang Chen, N. Fisicaro, T. Shinkel, V. Aitken, M. Katerelos, B. Denderen, M. Tange, R. Crawford, A. Robins, M. Pearse, A. D'apice (1996)
Reduction in Gal‐α1,3‐Gal epitope expression in transgenic mice expressing human H‐transferaseXenotransplantation, 3
M. Sandrin, H. Vaughan, P. Dabkowski, I. McKenzie (1993)
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.Proceedings of the National Academy of Sciences of the United States of America, 90 23
C. Somerville, A. Kyriazis, A. McKenzie, J. Allison, M. Pearse, A. D'apice (1994)
Functional expression of human CD59 in transgenic mice.Transplantation, 58 12
Abstract: Transgenic expression of the human complement regulatory molecule CD59 in mice and genetic deletion of the major xenoantigen galactose α 1,3 galactose (Gal KO) each resulted in partial protection of spleen cells from lysis by human serum. These protective effects were additive when the two genetic modifications were combined. However, when the effects of these genetic modifications were examined in an ex vivo model in which mouse hearts were perfused with human plasma, it was Gal KO which was the modification which determined protection. CD59 expression alone was not protective and CD59 expression in combination with Gal knockout did not result in a significant additional increase in protection over and above that provided by Gal knockout alone. The likely explanation for this discrepancy between the in vitro and ex vivo data is that the H2‐Kb promoter used to drive CD59 expression results I in substantially less expression on endothelium than on spleen cells.
Xenotransplantation – Wiley
Published: Feb 1, 1997
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.